Basic gene annotations are collected from Uniprot
and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser
is available.
MAX - MYC associated factor X
Function
Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5'-CAC[GA]TG-3'. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 'Lys-9' histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements.
Uniprot BrowserEntrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
---|---|---|---|
4149 | ENSG00000125952 | MAX | P61244 |
Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator
which then might up- down-regulates a regulon
that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows with ENSG00000125952 as Regulator
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-00705 | HMCN1 | up-regulates | MAX | activates | R-3493 | 18 | 6 | Drugs (21) Regulator Drugs (0)Regulon Drugs (21)TRELAGLIPTIN SUCCINATE, VILDAGLIPTIN, ALOGLIPTIN BENZOATE, SAXAGLIPTIN, ANAGLIPTIN, ENIBARCIMAB, TENELIGLIPTIN, CARMEGLIPTIN, BEGELOMAB, OMARIGLIPTIN, SAXAGLIPTIN HYDROCHLORIDE, GEMIGLIPTIN, BISEGLIPTIN, SITAGLIPTIN, DUTOGLIPTIN, EVOGLIPTIN, ALOGLIPTIN, LINAGLIPTIN, TRELAGLIPTIN, GOSOGLIPTIN, SITAGLIPTIN PHOSPHATE |
CMF-00706 | HMCN1 | up-regulates | MAX | activates | R-3491 | 18 | 6 | Drugs (4) |
CMF-01674 | MMRN1 | up-regulates | MAX | activates | R-3503 | 18 | 2 | Drugs (4) |
CMF-01985 | PCDH9 | down-regulates | MAX | activates | R-3491 | 18 | 3 | Drugs (4) |
CMF-01986 | PCDH9 | down-regulates | MAX | activates | R-3501 | 18 | 3 | Drugs (2) |
CMF-03196 | GCC2 | down-regulates | MAX | activates | R-3493 | 18 | 1 | Drugs (21) Regulator Drugs (0)Regulon Drugs (21)TRELAGLIPTIN SUCCINATE, VILDAGLIPTIN, ALOGLIPTIN BENZOATE, SAXAGLIPTIN, ANAGLIPTIN, ENIBARCIMAB, TENELIGLIPTIN, CARMEGLIPTIN, BEGELOMAB, OMARIGLIPTIN, SAXAGLIPTIN HYDROCHLORIDE, GEMIGLIPTIN, BISEGLIPTIN, SITAGLIPTIN, DUTOGLIPTIN, EVOGLIPTIN, ALOGLIPTIN, LINAGLIPTIN, TRELAGLIPTIN, GOSOGLIPTIN, SITAGLIPTIN PHOSPHATE |
CMF-04425 | COL12A1 | up-regulates | MAX | activates | R-3501 | 18 | 3 | Drugs (2) |
CMF-08300 | KIF4A | down-regulates | MAX | activates | R-3491 | 18 | 2 | Drugs (4) |
CMF-11214 | NRK | up-regulates | MAX | activates | R-3501 | 18 | 1 | Drugs (2) |
CMF-13622 | FMN1 | up-regulates | MAX | activates | R-3501 | 18 | 4 | Drugs (2) |
CMF-13743 | TUBA3C | up-regulates | MAX | activates | R-3501 | 18 | 1 | Drugs (2) |
CMF-14162 | CD1D | up-regulates | MAX | activates | R-3491 | 18 | 2 | Drugs (4) |
CMF-14501 | PRKCD | down-regulates | MAX | activates | R-3503 | 18 | 4 | Drugs (4) |
CMF-14502 | PRKCD | down-regulates | MAX | activates | R-3493 | 18 | 4 | Drugs (21) Regulator Drugs (0)Regulon Drugs (21)TRELAGLIPTIN SUCCINATE, VILDAGLIPTIN, ALOGLIPTIN BENZOATE, SAXAGLIPTIN, ANAGLIPTIN, ENIBARCIMAB, TENELIGLIPTIN, CARMEGLIPTIN, BEGELOMAB, OMARIGLIPTIN, SAXAGLIPTIN HYDROCHLORIDE, GEMIGLIPTIN, BISEGLIPTIN, SITAGLIPTIN, DUTOGLIPTIN, EVOGLIPTIN, ALOGLIPTIN, LINAGLIPTIN, TRELAGLIPTIN, GOSOGLIPTIN, SITAGLIPTIN PHOSPHATE |
CMF-14503 | PRKCD | down-regulates | MAX | activates | R-3491 | 18 | 4 | Drugs (4) |
CMF-19826 | OR6C75 | up-regulates | MAX | activates | R-3503 | 18 | 1 | Drugs (4) |
CMF-21152 | SH3TC2 | up-regulates | MAX | activates | R-3491 | 18 | 2 | Drugs (4) |
CMF-24356 | SMCHD1 | up-regulates | MAX | activates | R-3491 | 18 | 1 | Drugs (4) |
CMF-29040 | OR51T1 | up-regulates | MAX | activates | R-3501 | 18 | 2 | Drugs (2) |
CMF-31268 | SHP2_SIGNALING | up-regulates | MAX | activates | R-3501 | 18 | 3 | Drugs (2) |
CMF-31494 | SIGNALING_EVENTS_MEDIATED_BY_TCPTP | up-regulates | MAX | activates | R-3501 | 18 | 3 | Drugs (2) |
CMF-31591 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | MAX | activates | R-3491 | 18 | 5 | Drugs (4) |
CMF-31593 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | MAX | activates | R-3501 | 18 | 5 | Drugs (2) |
CMF-32138 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | MAX | activates | R-3501 | 18 | 3 | Drugs (2) |